• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

寻找可变蛋白酶敏感性朊病毒病的遗传病因。

Search for a genetic cause of variably protease-sensitive prionopathy.

作者信息

Lian Yuan, Kotobelli Keisi, Hall Stacey, Talkowski Michael E, O'Donnell-Luria Anne, Vallabh Sonia M, Appleby Brian S, Minikel Eric Vallabh

机构信息

Program in Brain Health, Broad Institute of MIT and Harvard, Cambridge, MA, 02142, USA.

National Prion Disease Pathology Surveillance Center, Case Western Reserve University, Cleveland, OH, 44106, USA.

出版信息

medRxiv. 2025 Mar 17:2024.12.12.24318867. doi: 10.1101/2024.12.12.24318867.

DOI:10.1101/2024.12.12.24318867
PMID:39711705
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11661330/
Abstract

Variably protease-sensitive prionopathy (VPSPr) is a rare, atypical subtype of prion disease currently classified as sporadic. We performed exome sequencing and targeted sequencing of non-coding regions on genomic DNA from autopsy-confirmed VPSPr patients (N=67) in order to search for a possible genetic cause. Our search identified no potentially causal variants for VPSPr. The common polymorphism M129V was the largest genetic risk factor for VPSPr, with an odds ratio of 7.0. Other variants in and near exhibited association to VPSPr risk only in proportion to their linkage disequilibrium with M129V, and upstream expression quantitative trait loci showed no evidence of independent association to VPSPr risk. We cannot rule out the possibility of causal variants hiding in genomic regions or classes of genetic variation that our search did not canvas. Nevertheless, our data support the classification of VPSPr as a sporadic prion disease.

摘要

可变蛋白酶敏感性朊病毒病(VPSPr)是一种罕见的、非典型的朊病毒病亚型,目前归类为散发性疾病。我们对尸检确诊的VPSPr患者(N = 67)的基因组DNA进行了外显子组测序和非编码区靶向测序,以寻找可能的遗传病因。我们的搜索未发现VPSPr的潜在致病变异。常见的多态性M129V是VPSPr最大的遗传风险因素,优势比为7.0。其他基因内和附近的变异仅与其与M129V的连锁不平衡程度相关,与VPSPr风险相关,并且上游表达数量性状位点没有显示出与VPSPr风险独立相关的证据。我们不能排除致病变异隐藏在我们的搜索未涵盖的基因组区域或遗传变异类型中的可能性。然而,我们的数据支持将VPSPr归类为散发性朊病毒病。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eccf/11967739/909048e2e773/nihpp-2024.12.12.24318867v2-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eccf/11967739/49d6892f0f02/nihpp-2024.12.12.24318867v2-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eccf/11967739/35922b1266b0/nihpp-2024.12.12.24318867v2-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eccf/11967739/1d59651b6468/nihpp-2024.12.12.24318867v2-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eccf/11967739/909048e2e773/nihpp-2024.12.12.24318867v2-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eccf/11967739/49d6892f0f02/nihpp-2024.12.12.24318867v2-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eccf/11967739/35922b1266b0/nihpp-2024.12.12.24318867v2-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eccf/11967739/1d59651b6468/nihpp-2024.12.12.24318867v2-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eccf/11967739/909048e2e773/nihpp-2024.12.12.24318867v2-f0004.jpg

相似文献

1
Search for a genetic cause of variably protease-sensitive prionopathy.寻找可变蛋白酶敏感性朊病毒病的遗传病因。
medRxiv. 2025 Mar 17:2024.12.12.24318867. doi: 10.1101/2024.12.12.24318867.
2
Search for a genetic cause of variably protease-sensitive prionopathy.寻找可变蛋白酶敏感性朊病毒病的遗传病因。
PLoS Pathog. 2025 Aug 1;21(8):e1013343. doi: 10.1371/journal.ppat.1013343. eCollection 2025 Aug.
3
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.系统性药理学治疗慢性斑块状银屑病:网络荟萃分析。
Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4.
4
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.慢性斑块状银屑病的全身药理学治疗:一项网状Meta分析。
Cochrane Database Syst Rev. 2020 Jan 9;1(1):CD011535. doi: 10.1002/14651858.CD011535.pub3.
5
Direct-acting antivirals for chronic hepatitis C.用于慢性丙型肝炎的直接作用抗病毒药物。
Cochrane Database Syst Rev. 2017 Sep 18;9(9):CD012143. doi: 10.1002/14651858.CD012143.pub3.
6
Neuropathologically-directed profiling of somatic and germline variants in sporadic human prion disease.散发性人类朊病毒病中体细胞和种系变异的神经病理学导向分析
bioRxiv. 2024 Jun 29:2024.06.25.600668. doi: 10.1101/2024.06.25.600668.
7
Neuropathologically directed profiling of PRNP somatic and germline variants in sporadic human prion disease.神经病理学导向的散发性人类朊病毒病 PRNP 体细和种系变异分析。
Acta Neuropathol. 2024 Jul 24;148(1):10. doi: 10.1007/s00401-024-02774-2.
8
Sex as a prognostic factor for mortality in adults with acute symptomatic pulmonary embolism.性别作为急性症状性肺栓塞成年患者死亡率的一个预后因素。
Cochrane Database Syst Rev. 2025 Mar 20;3(3):CD013835. doi: 10.1002/14651858.CD013835.pub2.
9
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.在基层医疗机构或医院门诊环境中,如果患者出现以下症状和体征,可判断其是否患有 COVID-19。
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.
10
Pharmacological interventions for the treatment of delirium in critically ill adults.用于治疗重症成年患者谵妄的药物干预措施。
Cochrane Database Syst Rev. 2019 Sep 3;9(9):CD011749. doi: 10.1002/14651858.CD011749.pub2.

本文引用的文献

1
Fluid Biomarkers in Individuals at Risk for Genetic Prion Disease up to Disease Conversion.遗传朊病毒病风险个体在疾病转化前的体液生物标志物。
Neurology. 2024 Jul 23;103(2):e209506. doi: 10.1212/WNL.0000000000209506. Epub 2024 Jun 19.
2
Large-scale validation of skin prion seeding activity as a biomarker for diagnosis of prion diseases.大规模验证皮肤朊病毒接种活性作为朊病毒病诊断的生物标志物。
Acta Neuropathol. 2024 Jan 17;147(1):17. doi: 10.1007/s00401-023-02661-2.
3
A genomic mutational constraint map using variation in 76,156 human genomes.
基于 76156 个人类基因组的变异,绘制出基因组突变约束图谱。
Nature. 2024 Jan;625(7993):92-100. doi: 10.1038/s41586-023-06045-0. Epub 2023 Dec 6.
4
An autopsy case of variably protease-sensitive prionopathy with Met/Met homogeneity at codon 129.129 密码子处 Met/Met 纯合的变异性蛋白酶敏感朊病毒病尸检病例。
Neuropathology. 2023 Dec;43(6):486-495. doi: 10.1111/neup.12911. Epub 2023 May 30.
5
Disease stages and therapeutic hypotheses in two decades of neurodegenerative disease clinical trials.二十年神经退行性疾病临床试验中的疾病阶段和治疗假说。
Sci Rep. 2022 Oct 21;12(1):17708. doi: 10.1038/s41598-022-21820-1.
6
Estimation of the number of inherited prion disease mutation carriers in the UK.英国遗传性朊病毒病突变携带者数量的估计。
Eur J Hum Genet. 2022 Oct;30(10):1167-1170. doi: 10.1038/s41431-022-01132-8. Epub 2022 Jun 27.
7
seqr: A web-based analysis and collaboration tool for rare disease genomics.seqr:一个用于罕见病基因组学的基于网络的分析和协作工具。
Hum Mutat. 2022 Jun;43(6):698-707. doi: 10.1002/humu.24366. Epub 2022 Mar 21.
8
Identification of novel risk loci and causal insights for sporadic Creutzfeldt-Jakob disease: a genome-wide association study.识别散发性克雅氏病的新风险基因座和因果关系:全基因组关联研究。
Lancet Neurol. 2020 Oct;19(10):840-848. doi: 10.1016/S1474-4422(20)30273-8. Epub 2020 Sep 16.
9
The GTEx Consortium atlas of genetic regulatory effects across human tissues.GTEx 联盟人类组织遗传调控效应图谱
Science. 2020 Sep 11;369(6509):1318-1330. doi: 10.1126/science.aaz1776.
10
Diagnosis of prion diseases by RT-QuIC results in improved surveillance.通过 RT-QuIC 检测结果进行朊病毒病诊断可提高监测效果。
Neurology. 2020 Aug 25;95(8):e1017-e1026. doi: 10.1212/WNL.0000000000010086. Epub 2020 Jun 22.